Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
eli lilly
5
×
fda
5
×
life sciences
national blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
merck
moderna
abbvie
allergan
black diamond therapeutics
bladder cancer
blueprint medicines
boehringer ingelheim
cancer immunotherapy
What
companies
5
×
bio
drug
roundup
black
diamond
fda
ipo
leading
life
new
science
therapeutics
week
approval
approved
arena’s
arguments
big
biotech
bounty
cancer
cig
class
clinic
comeback
commercialized
competitors
continue
corner
deals
debut
decades
delivered
diamond’s
digital
disease
drugs
eluded
epidemic
Language
unset
Current search:
fda
×
companies
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More